What Does MGI Worldwide Do?

Total employees213
HeadquartersShenzhen
Founded1947

MGI Tech Co., Ltd. (MGI) is a global company committed to building core tools and technology to lead life science. MGI focuses on the R&D, manufacturing, and sales of DNA sequencing instruments, reagents, and related products. Their cutting-edge technologies empower a wide range of applications in research, clinical diagnostics, agriculture, and beyond, aiming to make high-quality, affordable genomic information accessible to all.

Where Is MGI Worldwide's Headquarters?

HQ Function

Serves as the central command for MGI's global operations, including core research and development, strategic planning, manufacturing oversight, and corporate functions.

Notable Features:

Features advanced R&D laboratories for genomics and life sciences, state-of-the-art manufacturing facilities for sequencing instruments and reagents, and modern office spaces designed for collaboration.

Work Culture:

Characterized by a strong emphasis on scientific innovation, rapid development cycles, and a collaborative environment. Employees are often highly skilled in biotechnology, engineering, and data science. The culture supports continuous learning and addressing complex biological challenges.

HQ Significance:

Serves as the core of MGI's global R&D and manufacturing network. Its location in Shenzhen, a global technology hub, provides access to a rich talent pool, advanced supply chains, and a supportive ecosystem for high-tech enterprises, crucial for MGI's mission to develop leading-edge life science tools.

Values Reflected in HQ: The headquarters embodies MGI's commitment to innovation through its R&D infrastructure, precision in its manufacturing capabilities, and a global outlook fostered by its central operational role. The focus on advanced technology and scientific rigor is evident in its design and function.

Location:

MGI has established a significant global footprint with operations, R&D centers, manufacturing facilities, and customer support networks spanning Asia-Pacific, Europe, the Americas, Africa and the Middle East. This allows MGI to serve a worldwide customer base in academic research, clinical diagnostics, pharmaceuticals, and applied markets, providing localized support and access to its advanced gene sequencing technologies.

Street Address:

Main Office Buildings 2&11, Beishan Industrial Zone, Yantian District

City:

Shenzhen

State/Province:

Guangdong

Country:

China

Where Else Does MGI Worldwide Operate Around the World?

Santa Clara, CA/USA

Address: 2901 Tasman Dr, Ste 112, Santa Clara, CA 95054, USA

To drive adoption of MGI's sequencing platforms and solutions in the Americas, supporting clinical and research institutions.

Riga/Latvia

Address: Rankas street 10, Riga, LV-1005, Latvia

To ensure efficient supply chain and manufacturing capabilities for the European market, facilitate regional R&D, and provide localized customer support.

Singapore/Singapore

Address: 20 Ayer Rajah Crescent, #06-01, Singapore 139964

To expand MGI's footprint in the diverse and growing APAC life sciences market, fostering collaborations and providing tailored solutions.

Buying Intent Signals for MGI Worldwide

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading MGI Worldwide? Meet the Executive Team

As of April 2025, MGI Worldwide' leadership includes:

Mu Feng (牟峰) - President, Vice Chairman, CEO
Jiang Hui (蒋慧) - Senior Vice President, CFO, Board Secretary
Ni Ming (倪明) - Senior Vice President
Liu Jian (刘健) - Senior Vice President
Duncan Yu - President of MGI Americas

Who's Investing in MGI Worldwide?

MGI Worldwide has been backed by several prominent investors over the years, including:

CITIC Private Equity Funds Management (Pre-IPO)
Goldstone Investment (Pre-IPO)
Green Pine Capital Partners (Pre-IPO)
Co-Stone Asset Management (Pre-IPO)
Publicly Traded on Shanghai Stock Exchange STAR Market (SSE: 688114)

What Leadership Changes Has MGI Worldwide Seen Recently?

Hire1
Exits0

MGI has been strategically strengthening its regional leadership teams, particularly in key growth markets like the Americas, with notable appointments aimed at enhancing its clinical and medical affairs capabilities and driving market expansion.

New Appointments:

Dr. David Dimmock, Dr. David Dimmock appointed as Chief Medical Officer for MGI Americas to spearhead clinical and medical affairs.

What Technology (Tech Stack) Is Used byMGI Worldwide?

Discover the tools MGI Worldwide uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

MGI Worldwide Email Formats and Examples

MGI commonly uses email formats such as [firstinitial][last]@mgi-tech.com or [first].[last]@mgi-tech.com. Variations might exist based on department or region.

[firstinitial][last]@mgi-tech.com

Format

jdoe@mgi-tech.com

Example

75%

Success rate

What's the Latest News About MGI Worldwide?

BioSpectrum AsiaApril 24, 2024

MGI and AITbiotech Announce Strategic Collaboration to Advance Precision Medicine in Southeast Asia

MGI Tech Co. Ltd. announced a strategic collaboration with AITbiotech Pte. Ltd., a Singapore-based genomics and biotechnology company, to enhance genomic sequencing capabilities and promote precision medicine across Southeast Asia....more

Business WireFebruary 7, 2024

MGI Tech Showcases DNBSEQ-G99 at Advances in Genome Biology and Technology (AGBT) General Meeting

MGI showcased its DNBSEQ-G99 sequencer at the AGBT 2024 General Meeting, highlighting its ultra-fast speed and flexibility for various genomic applications such as WGS, WES, RNA-Seq, and targeted sequencing....more

PR NewswireJanuary 9, 2024

MGI Tech Unveils DNBSEQ-T20×2CL for Clinical Sequencing, Empowering Precision Medicine

MGI announced the launch of DNBSEQ-T20×2CL, a clinical version of its ultra-high throughput sequencer, aiming to accelerate the adoption of genomic sequencing in clinical diagnostics and personalized medicine....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including MGI Worldwide, are just a search away.